0001179110-13-009034.txt : 20130524 0001179110-13-009034.hdr.sgml : 20130524 20130524075345 ACCESSION NUMBER: 0001179110-13-009034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130523 FILED AS OF DATE: 20130524 DATE AS OF CHANGE: 20130524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Russell Lesley CENTRAL INDEX KEY: 0001374636 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10865 FILM NUMBER: 13870199 MAIL ADDRESS: STREET 1: 41 MOORES RD. CITY: FRAZER STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 6174983300 MAIL ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 4 1 edgar.xml FORM 4 - X0306 4 2013-05-23 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001374636 Russell Lesley 100 HAYDEN AVENUE LEXINGTON MA 02421 1 0 0 0 Common Stock 2013-05-23 4 A 0 2300 A 8400 D Stock Option (Right to Buy) 21.94 2013-05-23 4 A 0 3800 A 2023-05-23 Common Stock 3800 3800 D Each restricted stock unit represents a contingent right to buy one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Third Amended and Restated 2007 Equity Incentive Plan (the "Plan") that will vest in twelve equal monthly installments over one year from the date of grant; however, delivery of the shares is deferred until the earlier of (a) three years from the date of grant and (b) the date of the director's separation from service to the Issuer. Not applicable. This total includes 6,100 unsettled restricted stock units previously reported in Table II. Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twelve equal monthly installments over one year from the date of grant. Nancy R. Smith, attorney-in-fact 2013-05-24